XML 48 R41.htm IDEA: XBRL DOCUMENT v2.4.0.8
Stock-Based Compensation (Details) (USD $)
3 Months Ended 6 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended 6 Months Ended 3 Months Ended 6 Months Ended 3 Months Ended 6 Months Ended 3 Months Ended 6 Months Ended
Jun. 30, 2013
Jun. 30, 2012
Jun. 30, 2013
Jun. 30, 2012
Jun. 30, 2012
Stock Options [Member]
Jun. 30, 2013
Stock Options [Member]
Jun. 30, 2012
Stock Options [Member]
Dec. 31, 2012
Stock Options [Member]
Jun. 28, 2013
Stock Options [Member]
Jun. 30, 2013
Restricted Stock [Member]
Jun. 30, 2013
Cost of revenue [Member]
Jun. 30, 2012
Cost of revenue [Member]
Jun. 30, 2013
Cost of revenue [Member]
Jun. 30, 2012
Cost of revenue [Member]
Jun. 30, 2013
Selling, general and administrative [Member]
Jun. 30, 2012
Selling, general and administrative [Member]
Jun. 30, 2013
Selling, general and administrative [Member]
Jun. 30, 2012
Selling, general and administrative [Member]
Jun. 30, 2013
Research and development [Member]
Jun. 30, 2012
Research and development [Member]
Jun. 30, 2013
Research and development [Member]
Jun. 30, 2012
Research and development [Member]
Stock-based compensation in the form of employee stock options and restricted stock [Abstract]                                            
Total stock-based compensation $ 338,000 $ 292,000 $ 670,000 $ 573,000             $ 5,000 $ 19,000 $ 11,000 $ 37,000 $ 291,000 $ 238,000 $ 575,000 $ 476,000 $ 42,000 $ 35,000 $ 84,000 $ 60,000
Tax effect on stock-based compensation 0 0 0 0                                    
Net effect on net income (loss) 338,000 292,000 670,000 573,000                                    
Effect on net income (loss) attributable to AXT, Inc. per common share [Abstract]                                            
Basic (in dollars per share) $ (0.01) $ (0.01) $ (0.02) $ (0.02)                                    
Diluted (in dollars per share) $ (0.01) $ (0.01) $ (0.02) $ (0.02)                                    
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                                            
Compensation costs related to unvested stock options not yet recognized           1,700,000                                
Value of estimated forfeitures           26,000                                
Weighted-average period of amortization           2 years 4 months 24 days       2 years 2 months 12 days                        
Weighted-average grant date fair value of stock options granted (in dollars per share) $ 0 $ 2.15 $ 0 $ 2.84                                    
Weighted average assumptions [Abstract]                                            
Expected term (in years) 4 years   4 years                                      
Volatility (in hundredths) 74.82%   73.74%                                      
Expected dividend (in hundredths) 0.00%   0.00%                                      
Risk-free interest rate (in hundredths) 0.56%   0.71%                                      
Number of options outstanding [Roll Forward]                                            
Options outstanding, beginning of period (in shares)           2,727,000                                
Granted (in shares)         24,000,000 0 104,000,000                              
Exercised (in shares)           (195,000)                                
Canceled and expired (in shares)           (38,000)                                
Options outstanding, end of period (in shares)           2,494,000   2,727,000                            
Options vested and expected to vest as of June 30, 2013 (in shares)           2,481,000                                
Options exercisable as of June 30, 2013 (in shares)           1,600,000                                
Weighted average exercise price [Roll Forward]                                            
Options outstanding, beginning of period (in dollars per share)           $ 3.28                                
Granted (in dollars per share)           $ 0                                
Exercised (in dollars per share)           $ 1.40                                
Canceled and expired (in dollars per share)           $ 4.30                                
Options outstanding, end of period (in dollars per share)           $ 3.41   $ 3.28                            
Options vested and expected to vest as of June 30, 2013 (in dollars per share)           $ 3.41                                
Options exercisable as of June 30, 2013 (in dollars per share)           $ 3.18                                
Weighted average Remaining Contractual Life [Abstract]                                            
Options outstanding, beginning of period           6 years 7 months 20 days   6 years 8 months 16 days                            
Options outstanding, end of period           6 years 7 months 20 days   6 years 8 months 16 days                            
Options vested and expected to vest, end of period           6 years 7 months 17 days                                
Option exercisable, end of period           5 years 6 months 4 days                                
Aggregate Intrinsic Value [Abstract]                                            
Options outstanding, beginning of period           1,353,000                                
Options outstanding, end of period           969,000   1,353,000                            
Options vested and expected to vest, aggregate intrinsic value           969,000                                
Options exercisable, end of period           938,000                                
Closing price (in dollars per share)                 $ 2.70                          
Shares [Roll Forward]                                            
Non-vested, beginning of period (in shares)                   238,723                        
Granted (in shares)                   43,636                        
Vested (in shares)                   (24,781)                        
Non-vested, end of period (in shares)                   257,578                        
Weighted Average Grant Date Fair Value [Roll Forward]                                            
Non-vested, beginning of period (in dollars per share)                   $ 4.27                        
Granted (in dollars per share)                   $ 2.75                        
Vested (in dollars per share)                   $ 4.44                        
Non-vested, end of period (in dollars per share)                   $ 4.00                        
Unrecognized compensation expense related to restricted stock awards                   $ 789,000